Company: CDT
Filing Date: 2025-07-08
Form Type: DEF 14A
Source: 0001641172-25-018242
Chunk: 38

Company: CDT Equity Inc.
Filing Date: 2025-07-08
Form: DEF 14A
Chunk 38
---
 other things, vote all of the shares of MURF common stock legally and beneficially owned by it in favor of the Business Combination. On September 20, 2023, the Sponsor voted all of the shares of MURF common stock then legally and beneficially owned by it in favor of the Business Combination.

Old Conduit Shareholder Lockup Agreements

Under the Merger Agreement, as a condition to receiving Common Stock of the Company after the closing of the Business Combination in respect of their Old Conduit shares, certain shareholders of Old Conduit executed lockup agreements pursuant to which such shareholders agreed not to sell, transfer or take certain other actions with respect to such shares of our Common Stock for a period of 180 days after the closing of the Business Combination, subject to certain customary exceptions.

Transactions with Corvus Capital Limited

Ownership of Common Stock

Corvus Capital Limited (“Corvus Capital”), an entity wholly-owned by Dr. Andrew Regan and of which Dr. Regan is the Chief Executive Officer, received 20,765 shares of our Common Stock, pursuant to the terms of the Merger Agreement, following the completion of the Business Combination. As of July 3, 2025, Corvus Capital owns 20,032 shares of our Common Stock directly and 118 shares of our Common Stock through its wholly-owned subsidiary, Algo Holdings, Inc., and 154,799 shares of Common Stock owned directly by Manoira, of which Corvus is owner of 99% of its equity interests, or in the aggregate approximately 7.28% of the outstanding shares of our Common Stock as at July 3, 2025. Dr. Regan, the Chief Executive Officer of Corvus Capital and 100% ultimate beneficial owner, is also our chief executive officer as of April 2025, and a member of our Board. He received director fees of $842,081 during the year ended December 31, 2023, and director fees of $0 during the year ended December 31, 2024.

| 25 |

Pledges and Dispositions of Common Stock

Without the Company’s knowledge, on or around February and March 2024, Dr. Regan, through Corvus Capital Limited, a wholly owned subsidiary, entered into certain loan and pledge agreements that resulted in the disposition, during the first half of July 2024, of approximately 10,000 shares of the Company’s Common Stock held by such entity